Vitamin D supplementation during TB treatment improves patient symptoms, but does not accelerate the clearance of TB bacteria.

Nirsevimab is protective against RSV infections and coinfections, which suggests there is no replacement of RSV with other viruses post-nirsevimab administration.

The FDA will review a new prefilled syringe presentation of Shingrix (zoster vaccine recombinant, adjuvanted).

COVID-19 was associated with more severe disease outcomes than influenza or RSV during the 2022 to 2023 season.

People still see COVID-19 as an ongoing public health threat, even though the pandemic officially ended in 2023.

For patients with HPV16-positive CIN3, vaccination with a replication-incompetent Semliki Forest virus vaccine encoding HPV16 E6 and E7 is safe and shows clinical effectiveness.

Heat-related deaths are expected to climb throughout Europe this century due to climate change, according to study findings.